Medicine and Dentistry
Acute Myeloid Leukemia
100%
Childhood Cancer
66%
Pediatric Acute Myeloid Leukemia
48%
Cohort Analysis
40%
Acute Lymphoblastic Leukemia
34%
Disease
33%
Malignant Neoplasm
29%
Pediatrics
25%
Overall Survival
24%
Hematopoietic Stem Cell Transplantation
23%
Minimal Residual Disease
22%
Late Effect
20%
Myelodysplastic Syndrome
19%
Down Syndrome
18%
Leukemia
18%
Pediatric Hematology
17%
Hazard Ratio
16%
Pediatric Oncology
16%
Event Free Survival
15%
Acute Myelogenous Leukemia
14%
Leukemia in Children
12%
Somatics
12%
Adolescent
11%
Myeloid Leukemia
11%
Juvenile Myelomonocytic Leukemia
10%
Flow Cytometry
10%
Karyotype
10%
Pediatrics Patient
9%
Neoplasm
9%
Retrospective Study
9%
Prognostic Factor
9%
Central Nervous System
8%
Symptom
8%
Cumulative Incidence
8%
Randomized Controlled Trial
7%
Diagnosis
7%
Diagnostic Error
7%
Cancer Registry
7%
Infection
7%
Central Nervous System Tumor
6%
Cytopenia
6%
Ganglioneuroblastoma
6%
Wilms' Tumor
6%
Leukocyte
6%
Clinical Trial
5%
Cell Count
5%
Hemophagocytic Syndrome
5%
Brain Tumor
5%
Survival Rate
5%
Osteosarcoma
5%
Biochemistry, Genetics and Molecular Biology
Myeloid
49%
Germ Cell
16%
Cohort Study
15%
Germline
13%
Genetics
12%
Hematopoietic Stem Cell Transplantation
11%
Cytogenetics
10%
Karyotype
10%
GATA2
9%
Down Syndrome
8%
RUNX1
8%
Event Free Survival
8%
Overall Survival
7%
Cancer Registry
6%
Retrospective Study
6%
Population
6%
Thiopurine Methyltransferase
5%
Monosomy
5%
PTPN11
5%
Cisplatin
5%
Allele
5%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
32%
Acute Lymphoblastic Leukemia
13%
Malignant Neoplasm
12%
Down Syndrome
11%
Leukemia
10%
Childhood Cancer
10%
Disease
9%
Cohort Study
9%
Chemotherapy
8%
Event Free Survival
7%
Myelodysplastic Syndrome
6%
Juvenile Myelomonocytic Leukemia
5%
Juvenile Rheumatoid Arthritis
5%
Overall Survival
5%
Minimal Residual Disease
5%
Cisplatin
5%
Remission
5%
Promyelocytic Leukemia
5%
